MARIMED


Associated tags: Sale, CSE, Castle of Castro Marim

Locations: MARYLAND, DELAWARE, MASSACHUSETTS, MISSOURI, BOSTON, OHIO, NEW ENGLAND, CANADA, CHICAGO, CALIFORNIA, WHITE PLAINS, PUERTO RICO, UPPER MARLBORO, NEWTON, MA, US, INDIANA, ILLINOIS

MariMed Reports First Quarter 2024 Earnings

Retrieved on: 
Wednesday, May 8, 2024

MariMed management will host a conference call on Thursday, May 9, 2024 at 8:00 a.m. Eastern time, to discuss these results.

Key Points: 
  • MariMed management will host a conference call on Thursday, May 9, 2024 at 8:00 a.m. Eastern time, to discuss these results.
  • The conference call may be accessed through MariMed’s Investor Relations website, or by clicking the following link: MRMD Q124 Earnings Webcast .
  • During the first quarter, the Company announced the following developments in the implementation of its strategic growth plan:
    January 2: MariMed began selling its award-winning branded products through the Company's new wholesale business in Illinois.
  • March 6: MariMed announced the expansion of its Maryland footprint with the acquisition of its second dispensary in the state.

MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary

Retrieved on: 
Thursday, April 11, 2024

Thrive Casey is the only dispensary in Clark County, Illinois, 30 miles west of Terre Haute, Indiana.

Key Points: 
  • Thrive Casey is the only dispensary in Clark County, Illinois, 30 miles west of Terre Haute, Indiana.
  • Thrive Casey is located at 912 N. State Highway 49, near the intersection of state Highway 49 and U.S. Interstate 70.
  • MariMed also recently became vertical in Illinois, opening a craft grow and processing facility in Mt.
  • MariMed now distributes most of its products at Thrive dispensaries and wholesales its products to more than 100 other dispensaries throughout the state.

MariMed Partners with Iconic Boston Music Venues

Retrieved on: 
Wednesday, April 10, 2024

NORWOOD, Mass., April 10, 2024 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD) today announced a historic marketing partnership with two iconic venues in Boston, the MGM Music Hall Fenway and Citizens House of Blues Boston.

Key Points: 
  • NORWOOD, Mass., April 10, 2024 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD) today announced a historic marketing partnership with two iconic venues in Boston, the MGM Music Hall Fenway and Citizens House of Blues Boston.
  • This groundbreaking partnership marks Nature’s Heritage as the Exclusive Cannabis Sponsor, elevating the brand at highly anticipated shows to connect with millions of passionate music fans throughout the year.
  • With an onsite fan experience, prime real estate on venue video screens and digital ad space, Nature’s Heritage becomes part of unforgettable live music events at MGM Music Hall Fenway and Citizens House of Blues Boston.
  • Our partnership with these incredible venues will enable Nature’s Heritage to build a strong relationship with music fans when they are at their happiest – seeing one of their favorite bands,” said Jay O’Malley, MariMed Vice President of Marketing and Research & Development.

MariMed Closes Acquisition of Second Maryland Dispensary

Retrieved on: 
Tuesday, April 9, 2024

The Company expects to reopen the dispensary and begin adult-use retail sales by the end of the second quarter, upon regulatory approvals.

Key Points: 
  • The Company expects to reopen the dispensary and begin adult-use retail sales by the end of the second quarter, upon regulatory approvals.
  • This marks MariMed’s second adult-use Thrive Wellness dispensary in Maryland that the company owns and will be located at 9520 Marlboro Pike in Upper Marlboro, Maryland.
  • MariMed also owns and operates a Thrive Wellness dispensary in Annapolis and a cultivation and processing facility in Hagerstown.
  • MariMed’s branded cannabis products are distributed to virtually every dispensary in the state of Maryland.

MariMed Announces First Quarter 2024 Earnings Date

Retrieved on: 
Monday, April 8, 2024

NORWOOD, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report first quarter 2024 financial results on May 8, 2024 after the markets close.

Key Points: 
  • NORWOOD, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report first quarter 2024 financial results on May 8, 2024 after the markets close.
  • Management will host a conference call on May 9, 2024 at 8:00 a.m. EDT to discuss financial results.
  • A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q124 Earnings Webcast .
  • A playback of the call will also be made available on MariMed’s Investor Relations website.

A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois

Retrieved on: 
Tuesday, March 12, 2024

The only dispensary in Clark County, Thrive Casey is located at 912 N. State Highway 49, near the intersection of state Highway 49 and U.S. Interstate 70.

Key Points: 
  • The only dispensary in Clark County, Thrive Casey is located at 912 N. State Highway 49, near the intersection of state Highway 49 and U.S. Interstate 70.
  • Located just 30 miles from the border, it is the closest dispensary to Indiana, which has not passed a legal cannabis program.
  • MariMed also recently became vertical in Illinois, opening a craft grow and processing facility in Mt.
  • The Company now distributes most of its products at Thrive dispensaries and through the wholesale channel all over the state.

MariMed Reports Fourth Quarter and Full Year 2023 Earnings

Retrieved on: 
Wednesday, March 6, 2024

MariMed management will host a conference call on Thursday, March 7, 2024 at 8:00 a.m. Eastern time, to discuss these results.

Key Points: 
  • MariMed management will host a conference call on Thursday, March 7, 2024 at 8:00 a.m. Eastern time, to discuss these results.
  • The conference call may be accessed through MariMed’s Investor Relations website, or by clicking the following link: MRMD Q432 Earnings Call .
  • November 20: The Company announced a $58.7 million debt refinancing, lowering the Company's weighted average cost of debt to an industry low 8%.
  • Upon MCA approval of the license transfer, MariMed will apply for an adult-use dispensary license to commence recreational dispensary sales.

MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sleep

Retrieved on: 
Monday, March 4, 2024

NORWOOD, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Betty’s Eddies ™, the all-natural cannabis fruit chews handcrafted to fit a variety of needs, has launched a new flavor for consumers who want a pain-free, deep sleep: Ache Away Eddies PM.

Key Points: 
  • NORWOOD, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Betty’s Eddies ™, the all-natural cannabis fruit chews handcrafted to fit a variety of needs, has launched a new flavor for consumers who want a pain-free, deep sleep: Ache Away Eddies PM.
  • Ache Away Eddies PM may help ease inflammation and provide a restful night’s sleep by combining full spectrum cannabis with the most effective supporting cannabinoids and herbal supplements found in two of Betty’s Eddies best-selling fruit chews, Bedtime Betty's and Ache Away Eddies.
  • The blend of organic fruits and vegetables, CBN, CBC, Chamomile, Turmeric, and Piperine means sleeping is no longer a pain for those who chews the fast-acting and orange creme-flavored Ache Away Eddies PM.
  • Consumers can visit the Store Locator at www.bettyseddies.com to see where they can purchase Ache Away Eddies PM and the entire Betty’s Eddies line-up.

MariMed Introduces New and Improved Vibations™ Cannabis and Electrolyte Drink Mix

Retrieved on: 
Thursday, February 29, 2024

NORWOOD, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vibations, the cannabis and electrolyte drink mix that delivers advanced hydration, has released several new flavors and has been re-formulated to deliver a faster acting 15-minute onset.

Key Points: 
  • NORWOOD, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vibations, the cannabis and electrolyte drink mix that delivers advanced hydration, has released several new flavors and has been re-formulated to deliver a faster acting 15-minute onset.
  • Perfect for any on-the-go activity, Vibations provides a replenishing boost of focus and energy from its core formula of full-spectrum cannabis and hydrating electrolytes.
  • Vibations is developed and distributed by multi-state cannabis operator MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD).
  • The new Vibations line-up will be available in March at MariMed’s owned and operated dispensaries and other cannabis retailers throughout Massachusetts, Maryland, Illinois, and Delaware.

MariMed Announces Fourth Quarter and Full Year 2023 Earnings Date

Retrieved on: 
Monday, February 5, 2024

NORWOOD, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today it will report fourth quarter and full year 2023 financial results on March 6, 2024 after the markets close.

Key Points: 
  • NORWOOD, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today it will report fourth quarter and full year 2023 financial results on March 6, 2024 after the markets close.
  • Management will host a conference call on March 7, 2024 at 8:00 a.m. EST to discuss financial results.
  • A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q423 Earnings Webcast .
  • A playback of the call will also be made available on MariMed’s Investor Relations website.